Dr. Mohammad Dahrouj, MD, PhD

Dr. Dahrouj practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Dahrouj's NPI, 1891180428, was assigned on March 31, 2015. Dr. Dahrouj graduated from Medical University of South Carolina College of Medicine in 2015. Dr. Dahrouj holds Massachusetts license 278738.

Dr. Dahrouj's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Dahrouj's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Dahrouj is also affiliated with Brigham and Women's Hospital. The medical group on file is Wentworth-Douglass Hospital. Dmand AI also links Dr. Dahrouj to 1 more hospital, 1 community health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dahrouj practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Dahrouj's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Dahrouj's licenses on file in 2 states: Massachusetts and New Hampshire.

CMS data shows 5,120 Medicare services from Dr. Dahrouj across 11 procedure codes in 2024, for 954 Medicare patients. Medicare paid $397,592 for them.

CMS counts 954 Medicare patients who saw Dr. Dahrouj in 2024. The largest group is 75 to 84, with 389 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dahrouj's median patient age at 73, with 54% women.

In 2024, Dr. Dahrouj wrote 304 Medicare Part D claims for 92 patients. 72% of them were for generic drugs. CMS names the drug for 260 of them, across 8 drugs with 11 or more claims each, at $8,339 in total drug cost. In 2023, CMS named 200 claims across 5 drugs.

Dr. Dahrouj accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of cataract surgery by Dr. Dahrouj, more than 34% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Dahrouj, published from 2011 to 2023. 2014 was the busiest year, with 3. The most frequent topics are Retinal Pigment Epithelium, Tomography, Optical Coherence and Vascular Endothelial Growth Factor A. Dr. Dahrouj has published most often in Invest Ophthalmol Vis Sci. Dr. Dahrouj's most frequent co-authors are Oday Alsarraf, MD, PhD, Dean Eliott, MD and David Mingdar Wu, MD, PhD.

CMS Open Payments shows 67 general payments to Dr. Dahrouj from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Genentech, Inc. paid the most, $11,414.

Dr. Dahrouj graduated from Medical University of South Carolina College of Medicine in 2015.